| Type | Description |
|---|---|
| Definition | solute carrier family 34 member 2 |
| Date | Results | Publications |
|---|---|---|
| 2020-12-12 13:24:00 | SLC34A2 simultaneously promotes papillary thyroid carcinoma growth and invasion through distinct mechanisms. | 32005974 |
| 2020-10-03 12:52:00 | Phase Ia Study of Anti-NaPi2b Antibody-Drug Conjugate Lifastuzumab Vedotin DNIB0600A in Patients with Non-Small Cell Lung Cancer and Platinum-Resistant Ovarian Cancer. | 31540980 |
| 2020-07-25 12:54:00 | Findings suggest that solute carrier 34 A2 (SLC34A2) might be a potential therapeutic target for the therapy of glioma patients. | 30592329 |
| 2020-06-27 12:40:00 | he overexpression of EZH2 promotes colorectal cancer (CRC) cells proliferation and chemo-resistance to apoptosis. signaling pathway might serve as a novel therapeutic target against CRC. | 30038060 |
| 2020-02-08 10:49:00 | The results demonstrate that miR-25/Gsk3beta-mediated activation of Wnt signaling is responsible for SLC34A2-induced enhancement of neuroblastoma cell stemness. | 30868061 |
| Type | IDs |
|---|---|
| Synonymous | NAPI-3B, NAPI-IIb, NPTIIb |
| Gene |
UniProtKB-ID:
NPT2B_HUMAN
UniprotKB:
O95436
UniParc:
UPI000013DF24,
UPI0001D3B2A8
EMBL:
AF146796,
AK075015,
AC092436,
BC142704,
AF111856,
BC146666,
AH011306
Ensembl:
ENSG00000157765
KO:
hsa:10568
|
| Nucleutide sequences |
EMBL-CDS:
AAF31328.1,
AAI42705.1,
AAC98695.1,
AAI46667.1,
AAL55657.1,
BAC11354.1
Ensembl_TRS:
ENST00000645788,
ENST00000382051,
ENST00000504570,
ENST00000503434
|
| Protein sequencees |
Ensembl_PRO:
ENSP00000425501,
ENSP00000371483,
ENSP00000423021,
ENSP00000494094
RefSeq:
NP_006415.3,
NP_001171470.2,
NP_001171469.2
|
| Others |
UniRef100:
UniRef100_O95436
UniRef90:
UniRef90_O95436
UniRef50:
UniRef50_O95436
UniGene:
Hs.479372
CCDS:
CCDS3435.1,
CCDS54750.1
|
| {{proteinIndex+1}} | mRNA | Protein | UniprotKB | Description | ||||
|---|---|---|---|---|---|---|---|---|
| Refseq |
{{protein.nucleotideVersion}}
Ensembl: {{protein.nucleotideEnsembl}} |
{{protein.proteinVersion}}
Ensembl: {{protein.proteinEnsembl}} |
{{uniprot}} , |
Definition: {{{protein.definition}}}Transcript Veriant:{{protein.transcriptVeriant}} Status: {{protein.status}} |
||||
| Location | {{protein.contigId}} ( {{protein.positionStart}}..{{protein.positionEnd}} , {{protein.orientation}} ) | |||||||
| Conserved domain | Region: {{conservedDomain.region == '' || conservedDomain.region == null ? "-": conservedDomain.region}} GFID: {{conservedDomain.gfid == '' || conservedDomain.gfid == null ? "-": conservedDomain.gfid}} Family: {{conservedDomain.family == '' || conservedDomain.family == null ? "-": conservedDomain.family}} CDD: {{conservedDomain.cdd}} - |
{{conservedDomain.comments == '' || conservedDomain.comments == null ? "-" : conservedDomain.comments }} |
Region: {{conservedDomain.region == '' || conservedDomain.region == null ? "-": conservedDomain.region}} GFID: {{conservedDomain.gfid == '' || conservedDomain.gfid == null ? "-": conservedDomain.gfid}} Family: {{conservedDomain.family == '' || conservedDomain.family == null ? "-": conservedDomain.family}} CDD: {{conservedDomain.cdd}} - |
{{conservedDomain.comments == '' || conservedDomain.comments == null ? "-" : conservedDomain.comments }} |
||||
暂无数据
| 排名 | 科研单位 | 文献 |
|---|---|---|
| {{affIndex+1}} |
{{aff.value}} |
{{aff.size}} |
目前还没有研究热点单位
| 排名 | 研究人员 | 文献 |
|---|---|---|
| {{authorIndex+1}} |
{{author.value}} |
{{author.size}} |
目前还没有研究热点人员